Published in Int J Mol Epidemiol Genet on March 18, 2013
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med (2002) 3.39
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med (1990) 2.71
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol (1990) 1.94
Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens (1998) 1.93
Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry (2000) 1.66
Kawasaki disease: A brief history. Pediatrics (2000) 1.63
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol (1988) 1.35
Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child (1995) 1.34
A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet (2006) 1.30
TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol (1994) 1.29
Kawasaki syndrome. Clin Microbiol Rev (1998) 1.28
Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med (1989) 1.10
Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. Arthritis Rheum (1999) 1.09
Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther (2010) 1.08
Kawasaki disease: etiology, pathogenesis, and treatment. Cleve Clin J Med (2002) 1.07
Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology (1999) 1.04
Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res (2001) 1.00
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis (2003) 0.99
Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr (1992) 0.97
Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol (2007) 0.96
Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease. Scand J Immunol (1998) 0.92
Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr (1994) 0.92
Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol (2006) 0.92
The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr (1991) 0.91
Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum (2004) 0.91
Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE Study. Genet Med (2005) 0.89
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther (2007) 0.89
Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res (1996) 0.88
Polymorphisms in the 5'-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens (1999) 0.85
The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol (1995) 0.83
Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children. Hum Immunol (2006) 0.83
Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease. Infection (2002) 0.79
Acute hepatopancreatic necrosis disease (AHPND) outbreaks in Penaeus vannamei and P. monodon cultured in the Philippines. Dis Aquat Organ (2015) 0.83
Gene expression in tilapia following oral delivery of chitosan-encapsulated plasmid DNA incorporated into fish feeds. Mar Biotechnol (NY) (2005) 0.78